Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib versus placebo in severe COPD
2012-005586-13Phase 2Terminated
- Sponsor
- AB Science
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of masitinib in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by AB Science. Primary endpoint: Absolute change from randomisation in the 6-minute walking distance test at Week 24. Started Jun 2013; status: terminated.
02
Drugs
masitinib
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-005586-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005586-13.